Skip to main content

Global Consulting Firm Targets Expansion After Securing Major Norwegian Investment

To assist more corporates to meet net zero carbon ambitions and reduce energy consumption LONDON, Oct. 06, 2024 (GLOBE NEWSWIRE) — Projective is pleased to announce that Bonheur ASA, the Norway-based industrial investment company listed on the Oslo Stock Exchange, has acquired a controlling stake in the Company. Building on 176 years of experience in renewable energy, shipping, and various maritime activities, Bonheur has developed a strong ecosystem of renewable energy-related companies. Projective is a global technical consulting and engineering firm specialising in providing tailored solutions to large blue chip companies across various industries, including pharmaceuticals, food and beverage, FMCG, brewing and distilling, utilities, manufacturing, chemical processing, commercial and public real estate, and energy. Established...

Continue reading

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

— OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in breast cancer — On track to announce early clinical data for its lead program, OKI-219, in Q4-2024 — Post-transaction cash, cash equivalents, and short-term investments of approximately $139 million expected to provide funding through multiple clinical readouts and runway into Q4-2026 — Shares to trade on Nasdaq under the new ticker symbol “OKUR” commencing on October 7, 2024 BOULDER, Colo., Oct. 04, 2024 (GLOBE NEWSWIRE) — OnKure Therapeutics, Inc. (Nasdaq: OKUR) (“OnKure”), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines in oncology, today announced the completion of its previously announced merger of OnKure,...

Continue reading

Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant

NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”), a developer of psilocybin-based therapeutics, today provided an update on its previously announced proposed acquisition of Clairvoyant Therapeutics, Inc. Following the completion of necessary due diligence and other pre-closing activities specified in the conditional binding term sheet that was announced on September 9, 2024, Psyence Biomed has decided not to proceed with the acquisition at this time. Psyence Biomed continues to advance its recently initiated Phase IIb clinical trial of nature derived psilocybin in conjunction with psychotherapy as a potential treatment for Adjustment Disorder following a life-limiting cancer diagnosis in Palliative Care. The first patient is expected to...

Continue reading

Preliminary result of the subsequent offer period of Onni Bidco Oy’s voluntary recommended public cash tender offer for all the shares in Innofactor Plc

Innofactor Plc              Stock Exchange Release              October 4, 2024 at 6:35 p.m. (EEST) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. Preliminary result of the subsequent offer period of Onni Bidco Oy’s voluntary recommended public cash tender offer for all the shares in Innofactor Plc As announced on July 22, 2024, CapMan Growth Equity Fund III Ky, a fund managed by CapMan Group affiliated companies, (“CapMan Growth”), Sami Ensio, the founder, CEO and member of the Board of Directors of Innofactor Plc, through the holding company...

Continue reading

Additional Acceptance Period begins for MiddleGround Capital’s Voluntary Public Takeover Offer to shareholders of STEMMER IMAGING AG

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW.Shareholders can tender their shares during the additional acceptance period for EUR 48.00 per share in cash, which represents an attractive premium of approx. 52 percent to the closing price of the STEMMER IMAGING AG share on July 19, 2024. The additional acceptance period starts on October 5, 2024, and will end on October 18, 2024, at 24:00 hours (Frankfurt am Main local time).LEXINGTON, Ky., Oct. 04, 2024 (GLOBE NEWSWIRE) — The acceptance period for the voluntary public takeover offer (“Takeover...

Continue reading

Shipping Container Market is Projected to Develop at an Impressive 12.3% CAGR through 2031 | SkyQuest Technology

Westford,USA, Oct. 04, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the shipping container market will attain a value of USD 26.16 billion by 2031, with a CAGR of 12.3% over the forecast period (2024-2031). Rapidly expanding e-commerce activity and growing number of import and export operations around the world are projected to bolster the demand for shipping containers around the world. The signing of new trade agreements and growing international trade through seaways are also expected to uplift sales of shipping containers going forward.  Download a detailed overview: https://www.skyquestt.com/sample-request/shipping-container-market Browse in-depth TOC on “Shipping Container Market”Pages – 202 Tables – 63 Figures – 75Shipping Container Market Overview:Report Coverage DetailsMarket Revenue...

Continue reading

Biochar Market to Surpass Market Valuation of USD 700.7 Million by 2031 | SkyQuest Technology

The increasing application of the item in the processing of organic food and its efficiency in enhancing growth of crops and soil fertility is expected to be a key factor for the expansion of the market. Westford, USA, Oct. 04, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Biochar Market will reach a value of USD 700.7 Million by 2031, with a CAGR of 13.1% during the forecast period (2024-2031). The increasing application of the item in the processing of organic food and its efficiency in enhancing growth of crops and soil fertility is expected to be a key factor for the expansion of the market. Most of the European countries, including Austria and Switzerland, have enacted laws allowing the direct application of European Biochar Certificate to soil. A feedstock such as wood waste, manure, or agricultural waste is processed...

Continue reading

Global Sports Nutrition Market is Expected to Evolve at a High 7.4% CAGR through 2031 | SkyQuest Technology

Increasing number of people involved in sports activities around the world to improve their physical and mental health are also expected to increase the demand for sports nutrition over the coming years. Westford, USA, Oct. 04, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Sports Nutrition Market will attain a value of USD 81.8 billion by 2031, with a CAGR of 7.4% over the forecast period (2024-2031). Growing awareness regarding the benefits of sports nutrition among athletes around the world and advancements in sports nutrition is estimated to drive market growth. An increasing number of people involved in sports activities around the world to improve their physical and mental health are also expected to increase the demand for sports nutrition over the coming years. Request Sample of the Report on Sports Nutrition Market...

Continue reading

Form 8.3 – [ECKOH PLC – 03 10 2024] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ECKOH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC] – 03 10 2024 – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.